Back to Search
BRIAN WYNNE, MD
MD
Infectious Disease Physician
NPI: 1508673989Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD062475L(PA)
Research & Publications (20)
Bringing molecular tools into environmental resource management: untangling the molecules to policy pathway.
PMID 19338385·PLoS Biol·2009
7-preclinical
Implementation of the Strengths Model at an area mental health service.
PMID 19199129·Australas Psychiatry·2009
6-review
TNF-alpha knockout mice have increased corpora cavernosa relaxation.
PMID 19170842·J Sex Med·2009
7-preclinical
Grain size measurement by EBSD in complex hot deformed metal alloy microstructures.
PMID 17760627·J Microsc·2007
8-other
Recurrence of Kawasaki disease in an adult patient with cholecystitis.
PMID 17491541·Ir Med J·2007
5-case
Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains.
PMID 16999056·Ear Nose Throat J·2006
3-trial
An analysis of microband orientation in a commercial purity aluminium alloy subjected to forward and reverse torsion using Electron Backscatter Diffraction (EBSD).
PMID 16774518·J Microsc·2006
8-other
EBSD investigation of the microstructure and texture characteristics of hot deformed duplex stainless steel.
PMID 16774517·J Microsc·2006
8-other
Public engagement as a means of restoring public trust in science--hitting the notes, but missing the music?
PMID 16741352·Community Genet·2006
6-review
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
PMID 15664480·Int J Antimicrob Agents·2005
3-trial
Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children.
PMID 15933563·Pediatr Infect Dis J·2005
3-trial
Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
PMID 15616290·Antimicrob Agents Chemother·2005
3-trial
Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
PMID 14726431·J Antimicrob Chemother·2004
6-review
Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults.
PMID 12145727·Clin Infect Dis·2002
4-observational
Multinational study of pneumococcal serotypes causing acute otitis media in children.
PMID 12442021·Pediatr Infect Dis J·2002
4-observational
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
PMID 12385678·Int J Antimicrob Agents·2002
3-trial
Creating public alienation: expert cultures of risk and ethics on GMOs.
PMID 15971363·Sci Cult (Lond)·2001
8-other
Expert discourses of risk and ethics on genetically manipulated organisms: the weaving of public alienation.
PMID 15468486·Not Polit·2001
8-other
Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.
PMID 11734759·Pediatr Infect Dis J·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11340 BARTHOLOMEW RD
CHAGRIN FALLS, OH 44023 - Phone
- (215) 275-7630
Quick Facts
- NPI
- 1508673989
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile